Month: December 2025
Apple Wins New Trial in $300 Million LTE Patent Dispute with Optis Over Jury Verdict Form and Damages Evidence
December 2, 2025
Optis Cellular Tech., LLC v. Apple Inc Authored by: Jeremy J. Gustrowsky In a significant decision for patent litigation, the Federal Circuit has vacated a $300 million damages award against Apple Inc. in its ongoing dispute with Optis Cellular Technology,…
Read MoreWho Can Challenge Federal Contracts? Federal Circuit Clarifies “Interested Party” Rule in Percipient.Ai v. United States
December 2, 2025
Percipient.Ai, Inc. v. United States Authored by: Jeremy J. Gustrowsky In a major decision for government contractors and tech companies, the Federal Circuit recently clarified who has the right to challenge federal procurement decisions in Percipient.Ai, Inc. v. United States…
Read MoreAutomated Dumbbells Get Their Day: Federal Circuit Clarifies Patent Eligibility for Fitness Tech
December 2, 2025
Powerblock Holdings, Inc. v. IFit, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit reversed a lower court and ruled that PowerBlock Holdings, Inc.’s patent for automated dumbbells is eligible for patent protection. The case, PowerBlock…
Read MoreFederal Circuit Dismisses Realtek’s Appeal Over ITC Sanctions for Lack of Jurisdiction
December 2, 2025
Realtek Semiconductor Corp. v. Int’l Trade Comm’n Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit clarified the limits of its authority to review certain decisions made by the U.S. International Trade Commission (ITC). The case, Realtek…
Read MoreJury’s $10 Million Patent Damages Award Slashed to $1 After Expert Testimony Excluded
December 2, 2025
Rex Med., L.P. v. Intuitive Surgical, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed a dramatic reduction in damages in the case of Rex Medical, L.P. v. Intuitive Surgical, Inc., where a jury’s $10…
Read MoreFederal Circuit Clarifies Use of Applicant Admitted Prior Art in Patent Challenges
December 2, 2025
Shockwave Med., Inc. v. Cardiovascular Sys Authored by: Jeremy J. Gustrowsky In the recent case of Shockwave Medical, Inc. v. Cardiovascular Systems, Inc., the Federal Circuit addressed how “Applicant Admitted Prior Art” (AAPA) can be used in patent challenges before…
Read MoreSunkist Prevails in Trademark Dispute Over “KIST” Soda Branding
December 2, 2025
Sunkist Growers, Inc. v. Intrastate Distribs., Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the U.S. Court of Appeals for the Federal Circuit reversed a ruling by the Trademark Trial and Appeal Board (TTAB) and sided with Sunkist…
Read MoreFederal Circuit Strikes Down USAA’s Mobile Check Deposit Patent as Ineligible Abstract Idea
December 2, 2025
United Servs. Auto. Ass’n v. PNC Bank N.A Authored by: Jeremy J. Gustrowsky In a significant decision for financial technology patents, the Federal Circuit reversed a lower court’s ruling and found that United Services Automobile Association’s (USAA) patent on mobile…
Read MoreFederal Circuit Rejects Standing for Patent Owner Groups Challenging USPTO Rulemaking Denial
December 2, 2025
US Inventor, Inc. v. United States Pat. & Trademark Off Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed the dismissal of a lawsuit brought by US Inventor, Inc. and National Small Business United against the…
Read MoreFederal Circuit Reins in Presidential Tariff Powers Under IEEPA
December 2, 2025
V.O.S. Selections, Inc. v. Trump Authored by: Jeremy J. Gustrowsky In a landmark decision, the Federal Circuit has ruled that the President does not have unlimited authority to impose tariffs under the International Emergency Economic Powers Act (IEEPA). The case,…
Read MoreTax Win for Generics: Federal Circuit Says Hatch-Waxman Litigation Costs Are Deductible Business Expenses
December 2, 2025
Actavis Lab’ys FL, Inc. v. United States Authored by: Jeremy J. Gustrowsky In a major decision for the generic pharmaceutical industry, the Federal Circuit in Actavis Laboratories FL, Inc. v. United held that the legal expenses generic drug makers incur…
Read MoreFederal Circuit Affirms PTAB’s Finding of Obviousness in AliveCor v. Apple Patent Dispute
December 2, 2025
Alivecor, Inc. v. Apple Inc Authored by: Jeremy J. Gustrowsky In a closely watched case, the Federal Circuit has affirmed the Patent Trial and Appeal Board’s (PTAB) decision that all claims of three AliveCor patents related to wearable heart monitoring…
Read More